Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OVX836 phase 2b placebo-controlled influenza vaccine efficacy study in healthy adults
2024-520354-37-00Phase 2Completed
- Sponsor
- Osivax
- Start
- Jun 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial in influenza comparing OVX836 with Placebo (2 arms). Primary endpoint: First occurrence of RT-PCR-confirmed influenza Type A illness. Started Jun 2025; status: completed.
02
Drugs
OVX836
03
Conditions
influenza
Beyond the preview
Go deeper on 2024-520354-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520354-37-00.